Vattikuti Foundation- AIIMS join hands to offer succour to Parkinson's, essential tremors patients: Our Bureau, Mumbai Friday ...

Fremont, California Friday, February 14, 2025, 17:00 Hrs [IST] ...

Implantica receives positive feedback from US FDA for RefluxStop PMA Module 2 submission: Vaduz, Liechtenstein Friday, February 14, 2025, 18:00 Hrs [IST] Implantica AG (publ.), a ...

Rusan Pharma Ltd., is a global leader in pharmaceutical innovation, proudly announces that its chairman, Dr. Navin Saxena, ...

Antengene’s Xpovio approved for reimbursement in Taiwan to treat adult patients with relapsed/refractory multiple myeloma: Shanghai Friday, February 14, 2025, 16:00 Hrs [IST] An ...

Zydus and Synthon ink exclusive development, licensing & commercialization agreement for a novel 505(B)(2) oncology product for US market: Our Bureau, Mumbai Friday, February 14, ...

Pratteln, Switzerland Friday, February 14, 2025, 15:00 Hrs [IST] ...

Roche’s Evrysdi tablet receives US FDA approval for the treatment of spinal muscular atrophy: Basel Friday, February 14, 2025, 13:00 Hrs [IST] Roche, announced that the US Food ...

Glenmark Pharma introduces generic Xalatan ophthalmic solution, 0.005% in US: Our Bureau, Mumbai Friday, February 14, 2025, 12:15 Hrs [IST] Glenmark Pharmaceuticals Inc., USA (Gle ...

Sanofi announces update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study: Paris Friday, February 14, 2025, 12:00 Hrs [IST] A scheduled review of the E.mbrace p ...

Pfizer’s Adcetris combination regimen gets US FDA approval to treat relapsed/refractory diffuse large B-cell lymphoma: New York Friday, February 14, 2025, 11:00 Hrs [IST] Pfizer ...

The scheme for Strengthening of Medical Device Industry (SMDI), launched by the ministry of chemicals and fertilisers in November last year, is proposed to see the budget allocation doubling to Rs.